Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000662086 | SCV000784423 | uncertain significance | Familial hypokalemia-hypomagnesemia | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000662086 | SCV002812912 | uncertain significance | Familial hypokalemia-hypomagnesemia | 2024-04-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002530592 | SCV003443525 | uncertain significance | not provided | 2022-05-21 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 232 of the SLC12A3 protein (p.Ala232Thr). This variant is present in population databases (rs201318038, gnomAD 0.2%). This missense change has been observed in individual(s) with clinical features of SLC12A3-related conditions (PMID: 24696311). This variant is also known as A230T . ClinVar contains an entry for this variant (Variation ID: 548560). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC12A3 protein function. Experimental studies have shown that this missense change affects SLC12A3 function (PMID: 21157372). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV000662086 | SCV004040792 | uncertain significance | Familial hypokalemia-hypomagnesemia | 2023-02-01 | criteria provided, single submitter | clinical testing |